NZ197008A
(en)
*
|
1980-05-22 |
1984-10-19 |
Ici Ltd |
Acylanilide derivatives and pharmaceutical compositions
|
AU8961382A
(en)
*
|
1981-11-06 |
1983-05-12 |
Imperial Chemical Industries Plc |
Amide derivatives
|
US5236953A
(en)
*
|
1982-04-14 |
1993-08-17 |
Imperial Chemical Industries Plc |
Alkene, alkyne or cycloalkylene derivatives
|
GB8504093D0
(en)
*
|
1985-02-18 |
1985-03-20 |
Ici Plc |
Alkene alkyne/cycloalkylene derivatives
|
LU88769I2
(fr)
*
|
1982-07-23 |
1996-11-05 |
Zeneca Ltd |
Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
|
US4885289A
(en)
*
|
1983-12-12 |
1989-12-05 |
Breuer Miklos M |
Alteration of character of male beard growth
|
GB8406000D0
(en)
*
|
1984-03-07 |
1984-04-11 |
Ici Plc |
Olefine derivatives
|
GB8617652D0
(en)
*
|
1986-07-18 |
1986-08-28 |
Ici Plc |
Acylanilide derivatives
|
CA1327600C
(fr)
*
|
1987-05-22 |
1994-03-08 |
Ernest Felder |
Procede pour la preparation de derives 5-acylamino-2,4,6- triiodo-(ou tribromo-)benzoiques et de nouveaux derives correspondants de cet acide obtenus par ce procede
|
GB9214120D0
(en)
*
|
1991-07-25 |
1992-08-12 |
Ici Plc |
Therapeutic amides
|
EP0612211B1
(fr)
*
|
1991-11-05 |
2002-06-05 |
The Gillette Company |
Modification de la vitesse et du caractere de la croissance des cheveux
|
US5364885A
(en)
*
|
1992-11-13 |
1994-11-15 |
Ahluwalia Gurpreet S |
Reduction of hair growth
|
US6743419B1
(en)
|
1992-12-22 |
2004-06-01 |
The Gillette Company |
Method of reducing hair growth employing sulfhydryl active compounds
|
US5411991A
(en)
*
|
1992-12-22 |
1995-05-02 |
Shander; Douglas |
Method of reducing hair growth employing sulfhydryl active compounds
|
GB9305295D0
(en)
*
|
1993-03-15 |
1993-05-05 |
Zeneca Ltd |
Therapeutic compounds
|
GB9310095D0
(en)
*
|
1993-05-17 |
1993-06-30 |
Zeneca Ltd |
Therapeutic compounds
|
US5648394A
(en)
*
|
1993-05-27 |
1997-07-15 |
Boxall; Brian Alfred |
Topical composition for inhibiting hair growth
|
US6248751B1
(en)
|
1993-05-28 |
2001-06-19 |
Gurpreet S. Ahluwalia |
Inhibition of hair growth
|
US6414017B2
(en)
|
1993-05-28 |
2002-07-02 |
The Gillette Company |
Inhibition of hair growth
|
JPH0759644A
(ja)
*
|
1993-08-24 |
1995-03-07 |
Nobuyuki Yamamoto |
納骨用仏像
|
US5474763A
(en)
*
|
1994-03-11 |
1995-12-12 |
Shander; Douglas |
Reduction of hair growth
|
US5468476A
(en)
*
|
1994-03-16 |
1995-11-21 |
Ahluwalia; Gurpreet S. |
Reduction of hair growth
|
US5455234A
(en)
*
|
1994-03-16 |
1995-10-03 |
Ahluwalia; Gurpreet S. |
Inhibition of hair growth
|
EP0729363B1
(fr)
*
|
1994-06-27 |
2003-02-19 |
Neutron Therapies Inc. |
Analogues d'hormone contenant du bore et procedes d'utilisation de ces derniers pour visualiser ou eliminer des cellules pourvues de recepteurs d'hormones
|
US5554608A
(en)
*
|
1994-09-28 |
1996-09-10 |
Ahluwalia; Gurpreet S. |
Inhibition of hair growth
|
US5674477A
(en)
*
|
1995-02-28 |
1997-10-07 |
Ahluwalia; Gurpreet S. |
Reduction of hair growth
|
BR9607060A
(pt)
*
|
1995-02-28 |
1998-12-15 |
Handelman Joseph H |
Processos para inibição de crescimento de pelos em mamíferos uso de um inibidor não esteroidal de angiogénese processo para produção de uma composição para inibir o crescimento de pelos em mamíferos composição quando usada para inibir o crescimento de pelos em mamíferos
|
US5728736A
(en)
*
|
1995-11-29 |
1998-03-17 |
Shander; Douglas |
Reduction of hair growth
|
US5652273A
(en)
*
|
1995-11-30 |
1997-07-29 |
Henry; James |
Reduction of hair growth
|
FR2747039B1
(fr)
*
|
1996-04-05 |
1998-05-22 |
Oreal |
Utilisation du n-(3,4-dicyano-phenyl)- 3,3,3-trifluoro- 2-hydroxy-2-methylpropionamide pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
|
FR2745717B1
(fr)
*
|
1996-03-06 |
1998-04-17 |
Oreal |
Utilisation de n-aryl-2-hydroxyalkylamides pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
|
JP2000508296A
(ja)
|
1996-03-06 |
2000-07-04 |
ロレアル |
髪の成長の刺激または誘発および/または抜毛防止のためのn―アリール―2―ヒドロキシアルキルアミドの使用
|
US5908867A
(en)
*
|
1996-07-18 |
1999-06-01 |
Henry; James P. |
Reduction of hair growth
|
US5840752A
(en)
*
|
1996-11-21 |
1998-11-24 |
Henry; James P. |
Reduction of hair growth
|
US6492554B2
(en)
|
2000-08-24 |
2002-12-10 |
The University Of Tennessee Research Corporation |
Selective androgen receptor modulators and methods of use thereof
|
US6995284B2
(en)
*
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US7518013B2
(en)
*
|
2000-08-24 |
2009-04-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
US20050038110A1
(en)
*
|
2000-08-24 |
2005-02-17 |
Steiner Mitchell S. |
Selective androgen receptor modulators and methods of use thereof
|
US7759520B2
(en)
*
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US6071957A
(en)
*
|
1996-11-27 |
2000-06-06 |
The University Of Tennessee Research Corporation |
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
|
ZA9711121B
(en)
*
|
1996-12-13 |
1998-06-23 |
Handelman Joseph H |
Reduction of hair growth.
|
US6037326A
(en)
*
|
1996-12-31 |
2000-03-14 |
Styczynski; Peter |
Reduction of hair growth
|
DE19723722A1
(de)
*
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
US6160011A
(en)
*
|
1997-05-30 |
2000-12-12 |
The University Of Tennessee Research Corporation |
Non-steroidal agonist compounds and their use in male hormone therapy
|
US6245804B1
(en)
|
1997-05-30 |
2001-06-12 |
Schering Aktiengesellschaft |
Nonsteroidal gestagens
|
AU7723198A
(en)
*
|
1997-06-04 |
1998-12-21 |
University Of Tennessee Research Corporation, The |
Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
|
US5939458A
(en)
*
|
1997-09-22 |
1999-08-17 |
Henry; James P. |
Reduction of hair growth
|
US5958946A
(en)
*
|
1998-01-20 |
1999-09-28 |
Styczynski; Peter |
Modulation of hair growth
|
US6060471A
(en)
*
|
1998-01-21 |
2000-05-09 |
Styczynski; Peter |
Reduction of hair growth
|
GB9804648D0
(en)
|
1998-03-06 |
1998-04-29 |
Zeneca Ltd |
Chemical compounds
|
GB9805520D0
(en)
|
1998-03-17 |
1998-05-13 |
Zeneca Ltd |
Chemical compounds
|
US20040176470A1
(en)
*
|
1998-05-07 |
2004-09-09 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
GB9811427D0
(en)
|
1998-05-29 |
1998-07-22 |
Zeneca Ltd |
Chemical compounds
|
US6020006A
(en)
*
|
1998-10-27 |
2000-02-01 |
The Gillette Company |
Reduction of hair growth
|
US6184249B1
(en)
*
|
1998-12-18 |
2001-02-06 |
Biophysica, Inc. |
Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
|
US6121269A
(en)
*
|
1999-02-22 |
2000-09-19 |
Henry; James P. |
Reduction of hair growth
|
DE60031699T2
(de)
|
1999-09-04 |
2007-08-30 |
Astrazeneca Ab |
Hydroxyacetamidobenzolsulfonamidderivate
|
ES2216940T3
(es)
|
1999-09-04 |
2004-11-01 |
Astrazeneca Ab |
Derivados n-fenilicos de 2-hidroxi-2-metil-3,3,3-trifluoropropanamida sustituidos que elevan la actividad de piruvato deshidrogenasa.
|
WO2001017942A1
(fr)
|
1999-09-04 |
2001-03-15 |
Astrazeneca Ab |
Amides inhibiteurs pour la pyruvate deshydrogenase
|
US6235737B1
(en)
*
|
2000-01-25 |
2001-05-22 |
Peter Styczynski |
Reduction of hair growth
|
US6299865B1
(en)
|
2000-05-02 |
2001-10-09 |
Peter Styczynski |
Reduction of hair growth
|
US7001911B2
(en)
|
2000-06-28 |
2006-02-21 |
Bristol-Myers Squibb Company |
Fused cyclic modulators of nuclear hormone receptor function
|
AU2001288213B2
(en)
|
2000-06-28 |
2005-04-14 |
Bristol-Myers Squibb Company |
Selective androgen receptor modulators and methods for their identification, design and use
|
US20040077605A1
(en)
*
|
2001-06-20 |
2004-04-22 |
Salvati Mark E. |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
AU2001277731A1
(en)
|
2000-08-09 |
2002-02-18 |
Welfide Corporation |
Fused bicyclic amide compounds and medicinal use thereof
|
EP1705174A1
(fr)
|
2000-08-24 |
2006-09-27 |
The University Of Tennessee Research Corporation |
Modulateurs selectifs du recepteur androgenique et procedes d'utilisation des ces derniers
|
US6838484B2
(en)
*
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
US7855229B2
(en)
*
|
2000-08-24 |
2010-12-21 |
University Of Tennessee Research Foundation |
Treating wasting disorders with selective androgen receptor modulators
|
US6998500B2
(en)
*
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7026500B2
(en)
*
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
US20070173546A1
(en)
*
|
2000-08-24 |
2007-07-26 |
Dalton James T |
Selective androgen receptor modulators and method of use thereof
|
US8008348B2
(en)
*
|
2001-12-06 |
2011-08-30 |
University Of Tennessee Research Foundation |
Treating muscle wasting with selective androgen receptor modulators
|
US20040260108A1
(en)
*
|
2001-06-25 |
2004-12-23 |
Dalton James T. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
US8445534B2
(en)
|
2000-08-24 |
2013-05-21 |
University Of Tennessee Research Foundation |
Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
|
US7622503B2
(en)
*
|
2000-08-24 |
2009-11-24 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7645898B2
(en)
*
|
2000-08-24 |
2010-01-12 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and method of use thereof
|
US7919647B2
(en)
*
|
2000-08-24 |
2011-04-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US6953679B2
(en)
|
2000-09-19 |
2005-10-11 |
Bristol-Myers Squibb Company |
Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
|
EP1854798A3
(fr)
*
|
2000-09-19 |
2007-11-28 |
Bristol-Myers Squibb Company |
Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
|
DE10051981A1
(de)
|
2000-10-20 |
2002-05-02 |
Bayer Ag |
Substituierte Phenyluracile
|
US20040131574A1
(en)
*
|
2001-02-07 |
2004-07-08 |
Bergeron Raymond J |
Method and composition for the control of hair growth
|
US20040087548A1
(en)
|
2001-02-27 |
2004-05-06 |
Salvati Mark E. |
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
US20060287282A1
(en)
*
|
2001-06-25 |
2006-12-21 |
Steiner Mitchell S |
Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
|
US7439271B2
(en)
|
2001-06-27 |
2008-10-21 |
The Gillette Company |
Reduction of hair growth
|
US7261878B2
(en)
*
|
2001-08-10 |
2007-08-28 |
The Gillette Company |
Reduction of hair growth
|
US6743822B2
(en)
|
2001-08-10 |
2004-06-01 |
The Gillette Company |
Reduction of hair growth
|
US20030036561A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Peter Styczynski |
Reduction of hair growth
|
US8853266B2
(en)
*
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
WO2003049675A2
(fr)
*
|
2001-12-06 |
2003-06-19 |
Gtx, Inc. |
Traitement de l'amyotrophie a l'aide de modulateurs selectifs du recepteur d'androgene
|
US20070161608A1
(en)
*
|
2001-12-06 |
2007-07-12 |
Dalton James T |
Selective androgen receptor modulators for treating muscle wasting
|
WO2003053920A1
(fr)
|
2001-12-13 |
2003-07-03 |
Sumika Fine Chemicals Co., Ltd. |
Cristaux de bicalutamide et leur procede de production
|
WO2003053358A2
(fr)
*
|
2001-12-19 |
2003-07-03 |
Bristol-Myers Squibb Company |
Composes heterocycliques condenses et leurs substances analogues, modulant la fonction du recepteur hormonal nucleaire
|
US20040198821A1
(en)
*
|
2002-01-29 |
2004-10-07 |
Hwang Cheng Shine |
Reduction of hair growth
|
US7160921B2
(en)
*
|
2002-01-29 |
2007-01-09 |
The Gillette Company |
Reduction of hair growth
|
BRPI0307699A2
(pt)
*
|
2002-02-07 |
2015-06-16 |
Gtx Inc |
Tratamento de hiperplasia benigna da próstata com sarms.
|
EP1487780A4
(fr)
*
|
2002-02-28 |
2005-11-16 |
Univ Tennessee Res Foundation |
Composes a substitution haloacetamide et azide et procedes d'utilisation associes
|
AU2003217304A1
(en)
*
|
2002-02-28 |
2003-09-16 |
The University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
US7772433B2
(en)
*
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
US7803970B2
(en)
*
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
KR20040101251A
(ko)
*
|
2002-02-28 |
2004-12-02 |
유니버시티 오브 테네시 리서치 파운데이션 |
다치환된 선택적 안드로겐 수용체 모듈레이터 및 이를사용하는 방법
|
US20030199584A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Ahluwalia Gurpreet S. |
Reduction of hair growth
|
US7741371B2
(en)
*
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
WO2003106401A1
(fr)
*
|
2002-06-17 |
2003-12-24 |
University Of Tennessee Research Foundation |
Modulateurs selectifs du recepteur des androgenes n-pontes et procedes d'utilisation
|
EP1562594A4
(fr)
*
|
2002-10-15 |
2008-12-17 |
Univ Tennessee Res Foundation |
Modulateurs selectifs du recepteur des androgenes a liaison methylene et procedes d'utilisation associes
|
US20040197928A1
(en)
*
|
2002-10-15 |
2004-10-07 |
Dalton James T. |
Method for detecting selective androgen receptor modulators
|
AU2003287075A1
(en)
*
|
2002-10-15 |
2004-05-04 |
Gtx, Inc. |
Treating obesity with selective androgen receptor modulators
|
US20050080054A1
(en)
*
|
2002-10-16 |
2005-04-14 |
Dalton James T. |
Treating androgen decline in aging male (ADAM)-associated conditions with SARMS
|
US20060276539A1
(en)
*
|
2002-10-16 |
2006-12-07 |
Dalton James T |
Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
|
US20040087810A1
(en)
*
|
2002-10-23 |
2004-05-06 |
Dalton James T. |
Irreversible selective androgen receptor modulators and methods of use thereof
|
US8309603B2
(en)
|
2004-06-07 |
2012-11-13 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US20040141935A1
(en)
*
|
2003-01-21 |
2004-07-22 |
Peter Styczynski |
Reduction of hair growth
|
US20040167103A1
(en)
*
|
2003-02-24 |
2004-08-26 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
US7015349B2
(en)
*
|
2003-03-26 |
2006-03-21 |
The Gillette Company |
Reduction of hair growth
|
US20050112075A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Hwang Cheng S. |
Reduction of hair growth
|
MXPA06000119A
(es)
*
|
2003-12-16 |
2006-03-21 |
Gtx Inc |
Profarmacos de moduladores receptores de androgenos selectivos y metodos de uso de los mismos.
|
US20050249685A1
(en)
*
|
2004-04-27 |
2005-11-10 |
Natalia Botchkareva |
Reduction of hair growth
|
US9889110B2
(en)
|
2004-06-07 |
2018-02-13 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator for treating hormone-related conditions
|
US9884038B2
(en)
|
2004-06-07 |
2018-02-06 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator and methods of use thereof
|
US20110237664A1
(en)
*
|
2004-06-07 |
2011-09-29 |
Dalton James T |
Selective androgen receptor modulators for treating diabetes
|
US20060258628A1
(en)
*
|
2004-07-20 |
2006-11-16 |
Steiner Mitchell S |
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
|
BRPI0519218A2
(pt)
*
|
2004-12-22 |
2009-01-06 |
Gillette Co |
reduÇço do crescimento de cabelos ou pÊlos
|
WO2006069192A1
(fr)
*
|
2004-12-22 |
2006-06-29 |
The Gillette Company |
Diminution de la pousse des poils due aux inhibiteurs de la survivine
|
US7618956B2
(en)
*
|
2005-05-31 |
2009-11-17 |
The Gillette Company |
Reduction of hair growth
|
US7709516B2
(en)
|
2005-06-17 |
2010-05-04 |
Endorecherche, Inc. |
Helix 12 directed non-steroidal antiandrogens
|
US10010521B2
(en)
|
2006-08-24 |
2018-07-03 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US9844528B2
(en)
|
2006-08-24 |
2017-12-19 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
JP5345534B2
(ja)
|
2006-08-24 |
2013-11-20 |
ユニバーシティ オブ テネシー リサーチ ファウンデーション |
置換アシルアニリドおよびそれらの使用方法
|
US9730908B2
(en)
|
2006-08-24 |
2017-08-15 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US9284345B2
(en)
|
2007-04-12 |
2016-03-15 |
Endorecherche, Inc. |
17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
|
US7968603B2
(en)
|
2007-09-11 |
2011-06-28 |
University Of Tennessee Research Foundation |
Solid forms of selective androgen receptor modulators
|
WO2013152170A1
(fr)
|
2012-04-04 |
2013-10-10 |
Catylix, Inc. |
Modulateurs sélectifs de récepteur d'androgène
|
US10987334B2
(en)
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
US9744149B2
(en)
|
2012-07-13 |
2017-08-29 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US9604916B2
(en)
|
2012-07-13 |
2017-03-28 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US9969683B2
(en)
|
2012-07-13 |
2018-05-15 |
Gtx, Inc. |
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
|
US10258596B2
(en)
|
2012-07-13 |
2019-04-16 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US10314807B2
(en)
|
2012-07-13 |
2019-06-11 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US9622992B2
(en)
|
2012-07-13 |
2017-04-18 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US9682960B2
(en)
|
2013-12-19 |
2017-06-20 |
Endorecherche, Inc. |
Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
|